The global market for Infectious Diseases Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.

The Infectious Diseases Molecular Diagnostics market is driven by the need for rapid and accurate diagnostics for infectious diseases and the increasing global incidence of such diseases. Molecular diagnostics offer advanced methods for detecting infectious pathogens and monitoring their genetic variations. The rise in emerging infectious diseases and the demand for point-of-care testing contribute to market growth as healthcare systems seek reliable tools for early detection and effective disease management. Moreover, advancements in diagnostic technologies, including nucleic acid amplification techniques and multiplex assays, align with improved sensitivity and specificity of infectious disease diagnosis. However, the market also faces challenges, including establishing standardized testing protocols and addressing cost barriers for widespread adoption. Additionally, ensuring accessibility and navigating regulatory approvals for new diagnostics can pose obstacles for manufacturers. To succeed, stakeholders must focus on developing innovative molecular diagnostic solutions, collaborating with public health agencies, and addressing the challenges to meet the increasing demand for rapid and accurate detection of infectious diseases.

This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics.

The Infectious Diseases Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Diseases Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Diseases Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Infectious Diseases Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Infectious Diseases Molecular Diagnostics Market
Segment by Type	Polymerase Chain Reaction PCR Molecular Hybridization Biochip Others
Segment by Application	Hospital Third-party Testing Agency Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Qiagen, Illumina, Abbott, Hologic, BioMerieux, Danaher (Cepheid), Myriad Genetics, DAAN Gene, Agilent, Genomic Health, BD, Foundation Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Diseases Molecular Diagnostics Market report?

Ans: The main players in the Infectious Diseases Molecular Diagnostics Market are Roche, Qiagen, Illumina, Abbott, Hologic, BioMerieux, Danaher (Cepheid), Myriad Genetics, DAAN Gene, Agilent, Genomic Health, BD, Foundation Medicine

What are the Application segmentation covered in the Infectious Diseases Molecular Diagnostics Market report?

Ans: The Applications covered in the Infectious Diseases Molecular Diagnostics Market report are Hospital, Third-party Testing Agency, Others

What are the Type segmentation covered in the Infectious Diseases Molecular Diagnostics Market report?

Ans: The Types covered in the Infectious Diseases Molecular Diagnostics Market report are Polymerase Chain Reaction PCR, Molecular Hybridization, Biochip, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polymerase Chain Reaction PCR

1.2.3 Molecular Hybridization

1.2.4 Biochip

1.2.5 Others

1.3 Market by Application

1.3.1 Global Infectious Diseases Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Third-party Testing Agency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Diseases Molecular Diagnostics Market Perspective (2020-2031)

2.2 Global Infectious Diseases Molecular Diagnostics Growth Trends by Region

2.2.1 Global Infectious Diseases Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Infectious Diseases Molecular Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Infectious Diseases Molecular Diagnostics Market Dynamics

2.3.1 Infectious Diseases Molecular Diagnostics Industry Trends

2.3.2 Infectious Diseases Molecular Diagnostics Market Drivers

2.3.3 Infectious Diseases Molecular Diagnostics Market Challenges

2.3.4 Infectious Diseases Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue

3.1.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Infectious Diseases Molecular Diagnostics Revenue

3.4 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Revenue in 2024

3.5 Global Key Players of Infectious Diseases Molecular Diagnostics Head office and Area Served

3.6 Global Key Players of Infectious Diseases Molecular Diagnostics, Product and Application

3.7 Global Key Players of Infectious Diseases Molecular Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases Molecular Diagnostics Breakdown Data by Type

4.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2026-2031)

5 Infectious Diseases Molecular Diagnostics Breakdown Data by Application

5.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Infectious Diseases Molecular Diagnostics Market Size (2020-2031)

6.2 North America Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)

6.4 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infectious Diseases Molecular Diagnostics Market Size (2020-2031)

7.2 Europe Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)

7.4 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Infectious Diseases Molecular Diagnostics Market Size (2020-2031)

9.2 Latin America Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Infectious Diseases Molecular Diagnostics Introduction

11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Qiagen

11.2.1 Qiagen Company Details

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Introduction

11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.2.5 Qiagen Recent Development

11.3 Illumina

11.3.1 Illumina Company Details

11.3.2 Illumina Business Overview

11.3.3 Illumina Infectious Diseases Molecular Diagnostics Introduction

11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.3.5 Illumina Recent Development

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Infectious Diseases Molecular Diagnostics Introduction

11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.4.5 Abbott Recent Development

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic Infectious Diseases Molecular Diagnostics Introduction

11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.5.5 Hologic Recent Development

11.6 BioMerieux

11.6.1 BioMerieux Company Details

11.6.2 BioMerieux Business Overview

11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Introduction

11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.6.5 BioMerieux Recent Development

11.7 Danaher (Cepheid)

11.7.1 Danaher (Cepheid) Company Details

11.7.2 Danaher (Cepheid) Business Overview

11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Introduction

11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.7.5 Danaher (Cepheid) Recent Development

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Details

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Introduction

11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.8.5 Myriad Genetics Recent Development

11.9 DAAN Gene

11.9.1 DAAN Gene Company Details

11.9.2 DAAN Gene Business Overview

11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Introduction

11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.9.5 DAAN Gene Recent Development

11.10 Agilent

11.10.1 Agilent Company Details

11.10.2 Agilent Business Overview

11.10.3 Agilent Infectious Diseases Molecular Diagnostics Introduction

11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.10.5 Agilent Recent Development

11.11 Genomic Health

11.11.1 Genomic Health Company Details

11.11.2 Genomic Health Business Overview

11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Introduction

11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.11.5 Genomic Health Recent Development

11.12 BD

11.12.1 BD Company Details

11.12.2 BD Business Overview

11.12.3 BD Infectious Diseases Molecular Diagnostics Introduction

11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.12.5 BD Recent Development

11.13 Foundation Medicine

11.13.1 Foundation Medicine Company Details

11.13.2 Foundation Medicine Business Overview

11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Introduction

11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025)

11.13.5 Foundation Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polymerase Chain Reaction PCR

Table 3. Key Players of Molecular Hybridization

Table 4. Key Players of Biochip

Table 5. Key Players of Others

Table 6. Global Infectious Diseases Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Infectious Diseases Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Infectious Diseases Molecular Diagnostics Market Share by Region (2020-2025)

Table 10. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Infectious Diseases Molecular Diagnostics Market Share by Region (2026-2031)

Table 12. Infectious Diseases Molecular Diagnostics Market Trends

Table 13. Infectious Diseases Molecular Diagnostics Market Drivers

Table 14. Infectious Diseases Molecular Diagnostics Market Challenges

Table 15. Infectious Diseases Molecular Diagnostics Market Restraints

Table 16. Global Infectious Diseases Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Infectious Diseases Molecular Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Infectious Diseases Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2024)

Table 19. Ranking of Global Top Infectious Diseases Molecular Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Infectious Diseases Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Infectious Diseases Molecular Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Infectious Diseases Molecular Diagnostics, Product and Application

Table 23. Global Key Players of Infectious Diseases Molecular Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Infectious Diseases Molecular Diagnostics Product

Table 51. Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Qiagen Company Details

Table 54. Qiagen Business Overview

Table 55. Qiagen Infectious Diseases Molecular Diagnostics Product

Table 56. Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Qiagen Recent Development

Table 58. Illumina Company Details

Table 59. Illumina Business Overview

Table 60. Illumina Infectious Diseases Molecular Diagnostics Product

Table 61. Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Illumina Recent Development

Table 63. Abbott Company Details

Table 64. Abbott Business Overview

Table 65. Abbott Infectious Diseases Molecular Diagnostics Product

Table 66. Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 67. Abbott Recent Development

Table 68. Hologic Company Details

Table 69. Hologic Business Overview

Table 70. Hologic Infectious Diseases Molecular Diagnostics Product

Table 71. Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Hologic Recent Development

Table 73. BioMerieux Company Details

Table 74. BioMerieux Business Overview

Table 75. BioMerieux Infectious Diseases Molecular Diagnostics Product

Table 76. BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 77. BioMerieux Recent Development

Table 78. Danaher (Cepheid) Company Details

Table 79. Danaher (Cepheid) Business Overview

Table 80. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product

Table 81. Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Danaher (Cepheid) Recent Development

Table 83. Myriad Genetics Company Details

Table 84. Myriad Genetics Business Overview

Table 85. Myriad Genetics Infectious Diseases Molecular Diagnostics Product

Table 86. Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 87. Myriad Genetics Recent Development

Table 88. DAAN Gene Company Details

Table 89. DAAN Gene Business Overview

Table 90. DAAN Gene Infectious Diseases Molecular Diagnostics Product

Table 91. DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 92. DAAN Gene Recent Development

Table 93. Agilent Company Details

Table 94. Agilent Business Overview

Table 95. Agilent Infectious Diseases Molecular Diagnostics Product

Table 96. Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 97. Agilent Recent Development

Table 98. Genomic Health Company Details

Table 99. Genomic Health Business Overview

Table 100. Genomic Health Infectious Diseases Molecular Diagnostics Product

Table 101. Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 102. Genomic Health Recent Development

Table 103. BD Company Details

Table 104. BD Business Overview

Table 105. BD Infectious Diseases Molecular Diagnostics Product

Table 106. BD Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 107. BD Recent Development

Table 108. Foundation Medicine Company Details

Table 109. Foundation Medicine Business Overview

Table 110. Foundation Medicine Infectious Diseases Molecular Diagnostics Product

Table 111. Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 112. Foundation Medicine Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Infectious Diseases Molecular Diagnostics Picture

Figure 2. Global Infectious Diseases Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Infectious Diseases Molecular Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Polymerase Chain Reaction PCR Features

Figure 5. Molecular Hybridization Features

Figure 6. Biochip Features

Figure 7. Others Features

Figure 8. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Infectious Diseases Molecular Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Third-party Testing Agency Case Studies

Figure 12. Others Case Studies

Figure 13. Infectious Diseases Molecular Diagnostics Report Years Considered

Figure 14. Global Infectious Diseases Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Infectious Diseases Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Infectious Diseases Molecular Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Infectious Diseases Molecular Diagnostics Market Share by Players in 2024

Figure 18. Global Top Infectious Diseases Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2024

Figure 20. North America Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Infectious Diseases Molecular Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Infectious Diseases Molecular Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Share by Region (2020-2031)

Figure 34. China Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Infectious Diseases Molecular Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Roche Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 50. Qiagen Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 51. Illumina Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 53. Hologic Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 54. BioMerieux Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 55. Danaher (Cepheid) Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 56. Myriad Genetics Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 57. DAAN Gene Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 58. Agilent Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 59. Genomic Health Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 60. BD Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 61. Foundation Medicine Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Helicobacter Pylori Test Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27S9781

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Infectious Diseases Molecular Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10K9685

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Angio Seal Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-21N10613

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Vaccine Syringes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19K10622

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions